ABEO insider plans Rule 144 sale of 13,578 shares

ABEO has a planned insider sale under Rule 144.

Rhea-AI Filing Summary

ABEO has a planned insider sale under Rule 144. A holder has filed to sell 13,578 shares of common stock through broker Stifel Nicolaus & Company Inc., with an aggregate market value of $73,233.00. The shares relate to an award of 38,535 restricted stock units the holder acquired from the issuer on 01/21/2026 as equity compensation, with the planned sale date around 01/22/2026 on the Nasdaq exchange.

The filing notes that 54,191,361 shares of common stock were outstanding, providing context for the size of the planned sale relative to the company’s total share count.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ABEO Form 144 filing disclose?

The Form 144 discloses a planned sale of 13,578 shares of ABEO common stock, with an aggregate market value of $73,233.00, to be sold on the Nasdaq through Stifel Nicolaus & Company Inc.

When are the ABEO shares expected to be sold under this Form 144?

The filing lists an approximate sale date of 01/22/2026 for the planned sale of ABEO common stock on the Nasdaq exchange.

How were the ABEO shares being sold under Rule 144 acquired?

The shares being sold stem from restricted stock units that were acquired from the issuer on 01/21/2026 as equity compensation, in an amount of 38,535 securities.

What is the size of the ABEO Rule 144 sale compared with shares outstanding?

The planned sale covers 13,578 shares, while the filing states that 54,191,361 shares of ABEO common stock were outstanding, giving context for the relatively small size of the transaction.

Which broker is handling the ABEO Form 144 planned sale?

The broker named for the Rule 144 transaction is Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102.

What type of ABEO security is involved in this Form 144?

The filing concerns sales of Common Stock of ABEO, to be sold on the Nasdaq exchange under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/22/2026 - 04:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001884342
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABEONA THERAPEUTICS INC.
SEC File Number	001-15771
Address of Issuer	6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OHIO 44103
Phone	646-813-4701
Name of Person for Whose Account the Securities are To Be Sold	O'Malley Brendan M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	13578	73233.00	54191361	01/22/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/21/2026	Restricted Stock Units	Issuer			38535	01/21/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	These shares were sold to cover for taxes pursuant to an RSA vesting event.
Date of Notice	01/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Brendan O'Malley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)